Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02749474 · ClinicalTrials.gov registry record
Maternal Cancer Diagnosis and Treatment During Pregnancy:a Database for Maternal, Fetal, and Neonatal Outcomes
A clinical trial of Pregnancy, Cancer, Cancer in Pregnancy, Gestational Breast Cancer, Pregnancy Related, sponsored by The Cooper Health System.
- Recruiting
- Registry status
- 400
- Enrollment target
- 1
- Study location
NCT02749474: Recruiting study of Pregnancy, Cancer, Cancer in Pregnancy, Gestational Breast Cancer, Pregnancy Related, sponsored by The Cooper Health System.
NCT02749474 is a study of Pregnancy, Cancer, Cancer in Pregnancy, Gestational Breast Cancer, Pregnancy Related that is actively recruiting participants, run by The Cooper Health System. The registered enrollment target is 400 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02749474, a study of Pregnancy, Cancer, Cancer in Pregnancy, Gestational Breast Cancer, Pregnancy Related, is actively recruiting participants, sponsored by The Cooper Health System.
- RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to follow the treatment options offered to pregnant women diagnosed with cancer and study the impact that their treatment or delay of treatment has on their own health and that of their children.
Conditions Studied
Study Locations (1)
New Jersey
- Cooper University Hospital - Camden
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2003-07 |
| Est. Completion | 2025-07 |
What NCT02749474 shows while recruiting
NCT02749474 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Pregnancy, Cancer, Cancer in Pregnancy, Gestational Breast Cancer, Pregnancy Related appearing as the primary indexed condition, and to 0 interventions.
NCT02749474 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT02749474 about?
NCT02749474 is a clinical study titled "Maternal Cancer Diagnosis and Treatment During Pregnancy:a Database for Maternal, Fetal, and Neonatal Outcomes". The objective of this study is to follow the treatment options offered to pregnant women diagnosed with cancer and study the impact that their treatment or delay of treatment has on their own health and that of their children.
What is the current status of trial NCT02749474?
This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2003-07. Estimated completion is 2025-07.
What conditions does trial NCT02749474 study?
This clinical trial studies the following conditions: Pregnancy, Cancer, Cancer in Pregnancy, Gestational Breast Cancer, Pregnancy Related.
Who is sponsoring clinical trial NCT02749474?
This trial is sponsored by The Cooper Health System, which has 39 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02749474 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia